Nugent Lisa, Anthony Kouyate Robin, Jackson Shawna, Smith Meredith Y
Amgen, Thousand Oaks, CA, United States.
JMIR Res Protoc. 2022 Mar 22;11(3):e16430. doi: 10.2196/16430.
Involving chronically ill patients in the management of their health is widely recognized as a vital component of high-quality health care. However, to assume the role of informed participants, patients need both access to their health information and assistance in interpreting such data. Smartphone technology with SMS text messaging functionality offers a convenient and minimally demanding mechanism for providing such dual capabilities to patients. To date, a number of similar digital tools have been developed for use in various chronic and progressive disease conditions, including rheumatoid arthritis.
This paper aims to describe the development of a research protocol that applies a human-centered design (HCD) approach to develop a mobile health (mHealth) intervention to support symptom management and treatment adherence for rheumatoid arthritis.
To guide the development of the mHealth intervention for use within a commercial biotechnology context, we selected and applied an HCD framework consisting of three phases: understanding, ideation, and implementation.
Leveraging the framework, we mapped the key objectives and research questions to each phase and identified the HCD techniques and methods most suitable for addressing them. In addition, we identified the need to include a fourth phase, one that referred to postimplementation assessment, which would enable evaluation of patient engagement and intervention impact on symptom self-management.
This paper presents a research protocol that applied an HCD framework to guide the development of an mHealth intervention within a commercial biotechnology context. This type of guidance is salient because commercial entities are becoming one of the leading producers of this type of intervention. However, the methodologies used and challenges faced from a research and development perspective are not well-represented in the published research literature to date. Our application of the HCD framework yielded important findings. Each phase of the HCD framework provided important guidance for increasing the likelihood that the final product would be understandable, acceptable, feasible, and engaging to use. Consistent with other researchers in the field of mHealth interventions, we identified the need to add a fourth phase to the HCD framework, one that focused on a postimplementation assessment to guide further improvements to support adoption in real-world settings.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/16430.
让慢性病患者参与自身健康管理已被广泛认为是高质量医疗保健的重要组成部分。然而，要承担明智参与者的角色，患者既需要获取自己的健康信息，也需要在解读这些数据方面得到帮助。具有短信功能的智能手机技术为向患者提供这种双重能力提供了一种便捷且要求不高的机制。迄今为止，已经开发了许多类似的数字工具用于各种慢性和进行性疾病状况，包括类风湿性关节炎。
本文旨在描述一项研究方案的制定，该方案采用以人为本的设计（HCD）方法来开发一种移动健康（mHealth）干预措施，以支持类风湿性关节炎的症状管理和治疗依从性。
为指导在商业生物技术背景下使用的移动健康干预措施的开发，我们选择并应用了一个由三个阶段组成的HCD框架：理解、构思和实施。
利用该框架，我们将关键目标和研究问题映射到每个阶段，并确定了最适合解决这些问题的HCD技术和方法。此外，我们确定需要纳入第四个阶段，即实施后评估阶段，这将能够评估患者的参与度以及干预措施对症状自我管理的影响。
本文提出了一项研究方案，该方案应用HCD框架来指导在商业生物技术背景下移动健康干预措施的开发。这种指导很重要，因为商业实体正成为这类干预措施的主要生产者之一。然而，从研发角度来看所使用的方法和面临的挑战在迄今为止已发表的研究文献中并未得到充分体现。我们对HCD框架的应用产生了重要发现。HCD框架的每个阶段都为提高最终产品易于理解、可接受、可行且便于使用的可能性提供了重要指导。与移动健康干预领域的其他研究人员一致，我们确定需要在HCD框架中增加第四个阶段，该阶段侧重于实施后评估，以指导进一步改进，支持在现实环境中的应用。
国际注册报告识别号（IRRID）：RR1-10.2196/16430。
